Hermetica Superfood Encyclopedia
The Short Answer
Neonauclea forsteri contains indole alkaloids (notably cadambine-type compounds) and benzoquinone derivatives inferred from close taxonomic relatives, which are hypothesized to contribute to its traditional wound-healing and antimicrobial applications. The most quantified preclinical data come from the related species Neonauclea purpurea, where analogous alkaloids and 2,6-dimethoxy-1,4-benzoquinone inhibited chloroquine-resistant Plasmodium falciparum in vitro at IC50 values of 6.6 μM and 11.3 μM respectively, providing the only available biochemical benchmarks for the genus.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordPuauakiga Neonauclea forsteri benefits
Puauakiga — botanical close-up
Health Benefits
**Wound Healing (Traditional)**
Samoan traditional medicine employs Puauakiga topically for wounds, consistent with the broad antimicrobial and anti-inflammatory properties observed across the Neonauclea genus; no controlled wound-healing studies on N. forsteri have been conducted to date.
**Potential Antimalarial Activity**
Based on Neonauclea purpurea data, indole alkaloid α-dihydrocadambine and the quinone compound 2,6-dimethoxy-1,4-benzoquinone showed in vitro inhibition of chloroquine-resistant P. falciparum (K1 strain) at IC50 6.6 μM and 11.3 μM, suggesting the genus harbors antiparasitic scaffolds relevant to N. forsteri.
**Alkaloid-Mediated Antimicrobial Properties**
Indole alkaloids such as cadambine, documented in related Neonauclea species, are known to disrupt microbial membrane integrity and inhibit key enzymatic pathways in bacteria and fungi, supporting traditional topical wound applications.
**Cytotoxic Selectivity Against Pathogens**: In N
purpurea studies, cadambine (compound 1) and α-dihydrocadambine (compound 2) showed no cytotoxicity to mammalian Vero cells, suggesting a selective action profile that, if shared by N. forsteri alkaloids, would favor therapeutic safety.
**Anti-inflammatory Potential**
Members of the Rubiaceae family frequently exhibit COX-pathway and NF-κB modulation via quinone and alkaloid constituents; this mechanism is plausible for Puauakiga based on structural analogy with characterized congeners, though direct evidence is absent.
**Antioxidant Activity**
Benzoquinone derivatives and indole alkaloids found in related Neonauclea species demonstrate free-radical scavenging capacity in vitro, which may partly underlie the wound-site protective effects reported in Pacific Island traditional practice.
Origin & History
Natural habitat
Neonauclea forsteri is a tropical tree native to the Pacific Islands, including Samoa, Fiji, and surrounding island groups, where it grows in humid lowland and montane forest environments. The species belongs to the family Rubiaceae, a large plant family that includes many medicinally significant genera such as Cinchona and Nauclea. Traditional cultivation and wild harvesting practices remain poorly documented in the scientific literature, though the tree is recognized in Samoan ethnobotanical tradition as a wound-treatment plant.
“Puauakiga holds a place in Samoan traditional medicine as a remedy applied to wounds, consistent with widespread Pacific Island use of Rubiaceae-family trees for their perceived antimicrobial and healing properties. The plant's Samoan name, Puauakiga, reflects indigenous botanical nomenclature that predates Western taxonomic classification, suggesting generations of observational medicinal use within island communities. Across Polynesia and Melanesia, bark decoctions and poultices from large-canopy trees in the coffee family (Rubiaceae) have historically served dual roles as wound dressings and fever remedies, a pattern that aligns with the alkaloid chemistry now being characterized in related species. Formal ethnobotanical surveys documenting preparation methods, dosing traditions, and ritualistic or ceremonial contexts for N. forsteri specifically have not been published in indexed scientific literature.”Traditional Medicine
Scientific Research
The published scientific literature contains no primary research articles directly investigating Neonauclea forsteri for bioactive compounds, pharmacological activity, or clinical outcomes, representing a significant evidentiary gap. Available phytochemical and pharmacological data derive exclusively from a bioassay-guided fractionation study of N. purpurea stem bark methanol extract, which is a closely related but taxonomically distinct species; direct chemical equivalence cannot be assumed. That single in vitro study identified three compounds and reported IC50 values against P. falciparum K1 strain, but did not progress to in vivo animal models, and no clinical trials exist for either species. The overall evidence base is therefore preclinical, genus-level, and limited to a single study design with no replications, human data, or validated biomarker outcomes.
Preparation & Dosage
Traditional preparation
**Traditional Topical Preparation (Samoan)**
Fresh or dried plant material (bark or leaves) prepared as a poultice or decoction applied directly to wounds; exact quantities and preparation protocols are undocumented in peer-reviewed sources.
**Methanol/Aqueous Bark Extract (Research Use)**
Stem bark has been extracted with methanol in laboratory settings for phytochemical fractionation; no standardized commercial extract exists.
**Standardization**
No standardization to marker compounds (e.g., cadambine percentage) has been established for N. forsteri; standardization benchmarks from N. purpurea research have not been validated for commercial use.
**Effective Dose Range**
No effective dose range has been established for any indication; clinical dosing is entirely unknown.
**Forms Available**
Not available as a commercial dietary supplement; encountered only in traditional Pacific Island ethnomedicine contexts and academic phytochemistry research.
Nutritional Profile
Neonauclea forsteri has not been analyzed for macronutrient or micronutrient composition in any published study, and no nutritional database entry exists for the species. Based on the Rubiaceae family profile and the confirmed presence of indole alkaloids (cadambine class) and benzoquinone derivatives in closely related N. purpurea, the bark is expected to contain phenolic compounds, flavonoids, and tannins typical of tropical hardwood barks, though concentrations are unquantified for this species. Bioavailability of indole alkaloids from oral preparations is generally moderate in Rubiaceae species but has not been assessed for N. forsteri in any pharmacokinetic study. The plant is not consumed as a food source and therefore lacks relevance as a dietary macronutrient contributor.
How It Works
Mechanism of Action
Based on phytochemical analogy with Neonauclea purpurea, the likely active constituents of N. forsteri include cadambine-type indole alkaloids and 2,6-dimethoxy-1,4-benzoquinone, which may exert antiparasitic effects by interfering with heme detoxification pathways in Plasmodium falciparum, a mechanism common to quinone-class antimalarials. The benzoquinone moiety is capable of redox cycling, generating reactive oxygen species within parasite digestive vacuoles and potentially alkylating parasite proteins. Cadambine-class indole alkaloids may interact with topoisomerase enzymes or disrupt nucleic acid synthesis in microbial targets, consistent with the broad antimicrobial ethnopharmacological use. No receptor-binding assays, gene-expression studies, or enzyme-inhibition kinetics have been reported specifically for N. forsteri, and all mechanistic inferences remain extrapolated from structurally related compounds in the genus.
Clinical Evidence
No clinical trials have been conducted on Neonauclea forsteri or its congener N. purpurea in human subjects, and the ingredient has not been evaluated in any registered clinical study as of the current literature review. The only quantified efficacy data are from a single in vitro antimalarial assay using N. purpurea-derived compounds, yielding IC50 values that indicate mild-to-moderate antiparasitic potency but have not been translated to dose-response models, animal pharmacokinetics, or human pharmacodynamics. Effect sizes, confidence intervals, number-needed-to-treat estimates, and comparative efficacy against standard treatments are entirely undetermined. Confidence in any clinical claim remains very low, and the ingredient should be regarded as a subject for ethnopharmacological investigation rather than a clinically validated therapeutic agent.
Safety & Interactions
No human safety data, adverse event reports, or toxicology studies exist for Neonauclea forsteri, making a formal safety characterization impossible at this time. From the only available proxy data (N. purpurea in vitro studies), cadambine and α-dihydrocadambine showed no cytotoxicity to mammalian Vero cells, while 2,6-dimethoxy-1,4-benzoquinone exhibited weak cytotoxicity with an IC50 of 1.19 μM, raising a theoretical concern about cytotoxic potential at higher concentrations that requires in vivo validation. Drug interactions, contraindications, maximum safe doses, pregnancy and lactation guidance, and pediatric safety are entirely unknown; standard precautionary principles dictate avoidance during pregnancy and lactation and caution in individuals taking antiparasitic or hepatically metabolized medications until interaction data are available. Given the complete absence of clinical safety evidence, use outside traditional ethnomedicinal context and formal research settings is not currently supported by the scientific literature.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Neonauclea forsteriPuauakigaPacific NeonaucleaSamoan wound treeRubiaceae tropical bark
Frequently Asked Questions
What is Puauakiga used for in traditional Samoan medicine?
In Samoan traditional medicine, Puauakiga (Neonauclea forsteri) is applied to wounds, likely exploiting the antimicrobial and anti-inflammatory properties associated with alkaloids and phenolic compounds found in the Rubiaceae family. The preparation typically involves topical application of bark-derived material, though exact formulation details have not been formally documented in peer-reviewed ethnobotanical studies.
What bioactive compounds are found in Neonauclea forsteri?
No direct phytochemical analysis of Neonauclea forsteri has been published; however, the closely related species N. purpurea yields indole alkaloids cadambine and α-dihydrocadambine, along with 2,6-dimethoxy-1,4-benzoquinone from stem bark methanol extracts. These compounds are plausible constituents of N. forsteri given its taxonomic proximity, but chemical equivalence has not been confirmed analytically.
Does Neonauclea forsteri have antimalarial properties?
There are no direct antimalarial studies on Neonauclea forsteri; extrapolating from N. purpurea research, α-dihydrocadambine and 2,6-dimethoxy-1,4-benzoquinone inhibited chloroquine-resistant Plasmodium falciparum (K1 strain) in vitro at IC50 values of 6.6 μM and 11.3 μM respectively. These in vitro results represent preliminary findings only and have not been validated in animal models or human trials for either species.
Is Puauakiga safe to use as a supplement?
No human safety studies, toxicology assessments, or adverse event data exist for Neonauclea forsteri, making it impossible to establish a safety profile for supplemental use. The only indirect safety signal comes from in vitro data on N. purpurea showing weak cytotoxicity for one benzoquinone compound (IC50 1.19 μM), which has not been contextualized in an in vivo or human pharmacokinetic framework; use outside of traditional cultural contexts and controlled research settings is not recommended.
How does Puauakiga compare to other Neonauclea species medicinally?
Neonauclea purpurea is the most studied species in the genus and serves as the closest scientific reference point for N. forsteri, sharing stem bark alkaloid chemistry including cadambine-type indole alkaloids and quinone derivatives with demonstrated in vitro bioactivity. Neonauclea reticulata and other congeners also show antimicrobial and anti-inflammatory activities in preliminary studies, suggesting genus-wide pharmacological relevance, but species-specific profiles differ and direct comparative data for N. forsteri are unavailable.
What is the current state of clinical research on Puauakiga (Neonauclea forsteri)?
Clinical research on N. forsteri specifically is limited, with most studies focusing on related Neonauclea species like N. purpurea. Traditional use in Samoan medicine is well-documented, but controlled human trials evaluating efficacy and safety for wound healing or other therapeutic claims have not yet been conducted. Current evidence relies primarily on ethnobotanical documentation and preliminary laboratory studies of the genus.
Are there any known drug interactions with Puauakiga supplements?
Specific drug interaction data for N. forsteri is not available in the scientific literature due to limited clinical research. Given that Neonauclea species contain indole alkaloids with potential biological activity, caution is advised if combining with medications metabolized through cytochrome P450 pathways or those with antimalarial, sedative, or anti-inflammatory effects. Consultation with a healthcare provider is recommended before use, especially if taking prescription medications.
What forms of Puauakiga are available, and does the form affect how it works?
Puauakiga is traditionally prepared as a topical remedy or decoction in Samoan practice; commercial supplement forms (powders, capsules, extracts) vary by supplier but scientific data comparing bioavailability across forms is absent. The efficacy of different formulations has not been systematically evaluated, so traditional preparation methods may differ in effectiveness from standardized extract products. Standardization of active alkaloid content is not routinely performed for N. forsteri supplements.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w puauakiga-neonauclea-forsteri curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
